Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Free-Cash-Flow-To-The-Firm" stands at 41.64 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2022.
Eisai Co. Ltd.'s second quarter result of 19.82 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 824.37 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 19.82 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 148.76 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 41.64 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 39.80 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 30.38 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 30.38 Billion Japanese Yens.
The 3 year change is 49.09 Billion Japanese Yens.
The 5 year change is -36.61 Billion Japanese Yens.
The 10 year change is -1.45 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Free Cash Flow To The Firm | 905,699,262,464.00 |
![]() | Johnson & Johnson - Free Cash Flow To The Firm | 486,508,953,600.00 |
![]() | AbbVie Inc - Free Cash Flow To The Firm | 399,570,305,024.00 |
![]() | Roche Holding AG - Free Cash Flow To The Firm | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Free Cash Flow To The Firm | 280,205,508,085.11 |